Completed OBSERVATIONAL NCT03703401

The Role of Hydrosalpinx in Recurrent Miscarriage

Sponsor: Tommy's

Conditions Abortion, Spontaneous Hydrosalpinx Miscarriage, Recurrent

Interventions Hysterosalpingo-contrast-sonogram

Updated 6 times since 2018 Last updated: Nov 13, 2022 Started: Feb 28, 2018 Primary completion: Sep 11, 2020 Completion: Jan 15, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Abortion, Spontaneous and Hydrosalpinx and is currently completed. Tommy's leads this study, which shows 6 recorded versions since 2018 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Dec 2022 — Jul 2024 [monthly]

Completed

Status: Unknown Status → Completed
Jan 2021 — Dec 2022 [monthly]

Unknown Status
Nov 2020 — Jan 2021 [monthly]

Unknown Status

Status: Recruiting → Unknown Status

▶ Show 1 earlier version

Nov 2018 — Nov 2020 [monthly]

Recruiting

First recorded

Feb 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Tommy's
University of Birmingham

Data source: University of Birmingham

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Birmingham, United Kingdom